Catherine Schulte

Stock Analyst at Baird

(1.49)
# 1673
Out of 5,370 analysts
141
Total ratings
50.93%
Success rate
6.57%
Average return
18 Stocks
Name Action PT Current % Upside Ratings Updated
A Agilent Technologies
Maintains: Outperform
159 140
119.07 17.58% 16 May 22, 2025
MRVI Maravai LifeSciences
Maintains: Neutral
3 2
2.15 -6.98% 6 May 13, 2025
EXAS Exact Sciences
Maintains: Outperform
69 72
53.29 35.11% 14 May 2, 2025
AVTR Avantor
Maintains: Outperform
21 17
13.43 26.58% 11 Apr 28, 2025
TMO Thermo Fisher Scient...
Maintains: Outperform
603 573
404.82 41.54% 26 Apr 24, 2025
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Outperform
231 225
200.98 11.95% 9 Apr 23, 2025
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Neutral
1369 1034
1182.83 -12.58% 8 Apr 22, 2025
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Neutral
42 43
47.42 -9.32% 4 Apr 21, 2025
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Downgrades: Neutral
88 68
51.56 31.89% 10 Feb 19, 2025
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Outperform
182 165
n/a n/a 6 May 12, 2023
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Outperform
42 38
19.23 97.61% 7 Mar 1, 2023
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Outperform
56 33
35.01 -5.74% 3 Nov 21, 2022
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Downgrades: Neutral
4 2
n/a n/a 1 Jun 3, 2021
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Neutral
335 281
90.09 211.91% 6 Sep 22, 2020
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Initiates Coverage On: Outperform
21
n/a n/a 1 May 26, 2020
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Outperform
35 29
n/a n/a 5 Apr 7, 2020
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Neutral
208 217
347.88 -37.62% 7 Oct 30, 2019
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Outperform
17 20
168.2 -88.11% 1 Jun 28, 2018